PA8K PAION AG

EQS-News: PAION AG HAS FILED FOR THE OPENING OF INSOLVENCY PROCEEDINGS - PRELIMINARY INSOLVENCY ADMINISTRATOR APPOINTED

EQS-News: PAION AG / Key word(s): Insolvency
PAION AG HAS FILED FOR THE OPENING OF INSOLVENCY PROCEEDINGS - PRELIMINARY INSOLVENCY ADMINISTRATOR APPOINTED

31.10.2023 / 15:16 CET/CEST
The issuer is solely responsible for the content of this announcement.

PAION AG HAS FILED FOR THE OPENING OF INSOLVENCY PROCEEDINGS - PRELIMINARY INSOLVENCY ADMINISTRATOR APPOINTED

 

Aachen (Germany), 31 October 2023 - The specialty pharma company PAION AG (ISIN DE000A3E5EG5; Frankfurt Stock Exchange, Prime Standard: PA8) announces that, in accordance with the ad hoc announcement dated October 26, 2023, it filed for the opening of insolvency proceedings with the Local Court of Aachen, Insolvency Court, on Friday, October 27, 2023. Furthermore, an insolvency petition was also filed by PAION AG's subsidiary PAION Deutschland GmbH. Attorney Dr. Mark Boddenberg has been appointed as the preliminary insolvency administrator of PAION AG and PAION Deutschland GmbH.

 

Contact

Ralf Penner

SVP Investor Relations & Corporate Communications

PAION AG

Heussstrasse 25

52078 Aachen – Germany

Phone 2

E-mail

 

 

 


31.10.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at -news.com
Language: English
Company: PAION AG
Heussstraße 25
52078 Aachen
Germany
Phone: +49 (0)241-4453-0
Fax: +49 (0)241-4453-100
E-mail:
Internet:
ISIN: DE000A3E5EG5
WKN: A3E5EG
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Stuttgart, Tradegate Exchange
EQS News ID: 1761781

 
End of News EQS News Service

1761781  31.10.2023 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1761781&application_name=news&site_id=research_pool
EN
31/10/2023

Underlying

PA8KPAION AG

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on PAION AG

 PRESS RELEASE
Free
PA8K PAION AG

EQS-News: PAION AG: Sale of the business operations

EQS-News: PAION AG / Key word(s): Miscellaneous PAION AG: Sale of the business operations 22.12.2023 / 16:33 CET/CEST The issuer is solely responsible for the content of this announcement. PAION AG: Sale of the business operations   Aachen (Germany), 22 December 2023 - The Specialty Pharma Company PAION AG (ISIN DE000A3E5EG5; Frankfurt Stock Exchange, PA8) announces that PAION AG and its German subsidiary, PAION Deutschland GmbH, with the approval of the preliminary insolvency administrator of PAION AG and PAION Deutschland GmbH, attorney Dr. Mark Boddenberg, today con...

December 22, 2023 1 EN
 PRESS RELEASE
Free
PA8K PAION AG

EQS-News: PAION AG: Verkauf des Geschäftsbetriebes 

EQS-News: PAION AG / Schlagwort(e): Sonstiges PAION AG: Verkauf des Geschäftsbetriebes  22.12.2023 / 16:33 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. PAION AG: Verkauf des Geschäftsbetriebes    Aachen, 22. Dezember 2023 – Das Specialty-Pharma-Unternehmen PAION AG (ISIN DE000A3E5EG5; Frankfurter Wertpapierbörse, PA8) gibt bekannt, dass die PAION AG und ihre deutsche Tochtergesellschaft, die PAION Deutschland GmbH, mit Zustimmung des vorläufigen Insolvenzverwalters der PAION AG und der PAION Deutschland GmbH, Herrn Rechtsanwalt...

December 22, 2023 1 DE
 PRESS RELEASE
Free
PA8K PAION AG

EQS-News: PAION AG WECHSELT VOM PRIME STANDARD IN DEN GENERAL STANDARD

EQS-News: PAION AG / Schlagwort(e): Sonstiges PAION AG WECHSELT VOM PRIME STANDARD IN DEN GENERAL STANDARD 22.11.2023 / 16:05 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. PAION AG WECHSELT VOM PRIME STANDARD IN DEN GENERAL STANDARD   Aachen, 22. November 2023 – Das Specialty-Pharma-Unternehmen PAION AG (ISIN DE000A3E5EG5; Frankfurter Wertpapierbörse: PA8) gibt bekannt, dass ein Wechsel der Börsennotierung der PAION AG vom Prime Standard in den General Standard des regulierten Marktes der Frankfurter Wertpapierbörse erfolgt. Der ...

November 22, 2023 1 DE
 PRESS RELEASE
Free
PA8K PAION AG

EQS-News: PAION AG CHANGES FROM PRIME STANDARD TO GENERAL STANDARD

EQS-News: PAION AG / Key word(s): Miscellaneous PAION AG CHANGES FROM PRIME STANDARD TO GENERAL STANDARD 22.11.2023 / 16:05 CET/CEST The issuer is solely responsible for the content of this announcement. PAION AG CHANGES FROM PRIME STANDARD TO GENERAL STANDARD   Aachen, 22. November 2023 - The Specialty Pharma Company PAION AG (ISIN DE000A3E5EG5; Frankfurt Stock Exchange: PA8) announces that the stock exchange listing of PAION AG will be changed from the Prime Standard to the General Standard of the regulated market of the Frankfurt Stock Exchange. The revocation of th...

November 22, 2023 1 EN
 PRESS RELEASE
Free
PA8K PAION AG

EQS-News: PAION AG SIGNS STRATEGIC COOPERATION AGREEMENT WITH YICHANG ...

EQS-News: PAION AG / Key word(s): Miscellaneous PAION AG SIGNS STRATEGIC COOPERATION AGREEMENT WITH YICHANG HUMANWELL 21.11.2023 / 10:15 CET/CEST The issuer is solely responsible for the content of this announcement. PAION AG SIGNS STRATEGIC COOPERATION AGREEMENT WITH YICHANG HUMANWELL   Aachen, Germany, 21 November 2023 - The Specialty Pharma Company PAION AG (ISIN DE000A3E5EG5; Frankfurt Stock Exchange: PA8) announces the signing of a Memorandum of Understanding ("MOU") on a strategic cooperation with Yichang Humanwell at the China Innovation Conference. The cooperat...

November 21, 2023 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch